parecoxib pivolyl impurity

Parecoxib pivolyl impurity is a structurally related API impurity derived from the pivaloyloxymethyl prodrug moiety of parecoxib. It features a pivaloyl group (tert-butylcarbonyl) linked via an ether linkage to the cyclooxygenase-2 inhibitor scaffold, with a truncated valdecoxib core lacking the terminal sulfonamide. This impurity arises from incomplete esterification during synthetic processes, retaining a hydroxymethyl substituent at the prodrug site. It serves as an HPLC reference standard for quantifying process-related impurities in parecoxib drug substance.